CDC6 is a possible biomarker for hepatocellular carcinoma

CONCLUSIONS: The expression level of CDC6 in hepatocellular carcinoma is related tightly to clinical findings. Detecting the expression of CDC6 might provide a new biomarker for patients with hepatocellular carcinoma.PMID:34367412 | PMC:PMC8339721
Source: International Journal of Clinical and Experimental Pathology - Category: Pathology Authors: Source Type: research